diabetes

Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs
Seeking Alpha
Tue, 04/8/14 - 11:48 am
Oramed
MannKind
diabetes
ORMD-0801
US jury hits Takeda, Eli Lilly with $9 bln penalty
Yahoo/AP
Tue, 04/8/14 - 08:56 am
Takeda
Actos
Eli Lilly
diabetes
Takeda Showed Disregard in Handling Diabetes Drug, Jury Told
Bloomberg
Mon, 04/7/14 - 05:07 pm
Takeda
diabetes
Actos
FDA Keeps Driving Up Future Cost of Inhalable Insulin
Yahoo/247WallStreet
Mon, 04/7/14 - 12:56 pm
FDA
inhaled insulin
diabetes
Afrezza
MannKind
MannKind Announces FDA Extends PDUFA Date for AFREZZA By 3 Months
Yahoo/Benzinga
Mon, 04/7/14 - 08:44 am
FDA
Afrezza
diabetes
MannKind
Will The Third Time Be A Charm For MannKind? Leading Fund Managers Definitely Think So
Seeking Alpha
Sun, 04/6/14 - 10:23 am
MannKind
Afrezza
inhaled insulin
diabetes
How MannKind Shows Depth Of The Diabetes Market
Seeking Alpha
Thu, 04/3/14 - 08:59 am
MannKind
diabetes
Afrezza
After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin
Seeking Alpha
Wed, 04/2/14 - 09:52 pm
Bydureon
insulin
Bristol-Myers Squibb
diabetes
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wed, 04/2/14 - 07:46 am
FDA
Afrezza
diabetes
MannKind
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
Bloomberg
Tue, 04/1/14 - 10:20 pm
MannKind
inhaled insulin
Afrezza
FDA
diabetes
advisory panels
Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy
First Word Pharma
Tue, 04/1/14 - 03:34 pm
diabetes
Intarcia
exenatide
Mannkind: The Best Afrezza FDA Panel Preview Ever
TheStreet.com
Mon, 03/31/14 - 09:53 am
FDA
Afrezza
advisory panels
diabetes
MannKind
FDA staff review raises questions about MannKind diabetes device
Yahoo/Reuters
Sat, 03/29/14 - 09:13 am
MannKind
diabetes
type 2 diabetes
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
FOX Business
Fri, 03/28/14 - 01:00 pm
MannKind
FDA
Afrezza
insulin
diabetes
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
diabetes
Takeda
Sanofi
GSK
Victoza
Merck
insulin
Novo Nordisk
Afrezza
U300
Tresiba
Eli Lilly
MannKind And Afrezza's NDA Evaluation: What Is The Real Justification For The Advisory Committee?
Seeking Alpha
Fri, 03/28/14 - 08:21 am
MannKind
diabetes
Afrezza
FDA
advisory panels
AstraZeneca's New Diabetes Drug May Also Combat Alzheimer's Disease
Seeking Alpha
Thu, 03/27/14 - 05:00 pm
diabetes
Alzheimer's disease
AstraZeneca
Symlin
EU approves GSK's once-weekly diabetes drug
Reuters
Wed, 03/26/14 - 12:41 pm
Europe
GSK
diabetes
albiglutide
Novo CEO sees improved picture for Tresiba in U.S. market
Fierce Pharma
Mon, 03/24/14 - 12:13 pm
Novo Nordisk
Pharma CEOs
Tresiba
diabetes
Sanofi
insulin
Boehringer, Lilly Diabetes Drug Wins EU Panel’s Backing
Bloomberg
Fri, 03/21/14 - 09:41 am
Jardiance
diabetes
Boehringer Ingelheim
Eli Lilly
Europe

Pages